Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 25 of 121 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/17/17
End: 02/13/19
Due: 02/13/20
Phase: N/A
Priority: Normal
Start: 11/01/18
End: 02/28/19
Due: 02/28/20
Phase: N/A
Priority: Normal
Start: 11/20/23
End: 02/18/24
Due: 02/18/25
Phase: N/A
Priority: Normal
Start: 02/28/25
End: 05/05/25
Due: 05/05/26
Phase: N/A
Priority: Normal
Start: 01/09/20
End: 07/01/21
Due: 07/01/22
Phase: N/A
Priority: Normal
Start: 09/01/21
End: 02/17/22
Due: 02/17/23
Phase: N/A
Priority: Normal
Start: 05/01/17
End: 12/31/17
Due: 12/31/18
Phase: N/A
Priority: Normal
Start: 12/30/21
End: 09/30/22
Due: 09/30/23
Phase: N/A
Priority: Normal
Start: 07/01/15
End: 02/28/16
Due: 02/28/17
Phase: N/A
Priority: Normal
Start: 02/01/22
End: 07/15/23
Due: 07/15/24
Phase: N/A
Priority: Normal
Start: 02/03/25
End: 05/30/25
Due: 05/30/26
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 07/31/16
Due: 07/31/17
Phase: N/A
Priority: Normal
Start: 05/05/23
End: 06/30/24
Due: 06/30/25
Phase: N/A
Priority: Normal
Start: 05/30/23
End: 09/30/23
Due: 09/30/24
Antilipidemic Ezetimibe Induces Regression of Endometriotic Explants in a Rat Model of Endometriosis
Phase: N/A
Priority: Normal
Start: 09/01/19
End: 01/31/21
Due: 01/31/22
Phase: N/A
Priority: Normal
Start: 05/15/22
End: 11/15/22
Due: 11/15/23
Phase: N/A
Priority: Normal
Start: 03/01/24
End: 05/15/24
Due: 05/15/25
Phase: N/A
Priority: Normal
Start: 02/01/24
End: 06/15/25
Due: 06/15/26
Phase: N/A
Priority: Normal
Start: 05/31/25
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 01/27/25
End: 03/28/25
Due: 03/28/26
Phase: N/A
Priority: Normal
Start: 05/20/22
End: 05/01/23
Due: 05/01/24
Phase: N/A
Priority: Normal
Start: 06/01/18
End: 05/30/19
Due: 05/30/20
Phase: N/A
Priority: Normal
Start: 07/13/23
End: 07/18/24
Due: 07/18/25
Phase: N/A
Priority: Normal
Start: 05/01/22
End: 02/28/23
Due: 02/28/24
Phase: N/A
Priority: Normal
Start: 12/04/24
End: 07/31/25
Due: 07/31/26